Disclosure Panels Details Page
Esophageal/Gastric Cancers Panel - Disclosures as of 04/26/2024
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Jaffer Ajani MD | Amgen Inc. Astellas Pharma US, Inc. AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Delta Fly Pharma Gilead Sciences, Inc. Jazz Pharmaceuticals Inc. Merck & Co., Inc. Roche Laboratories, Inc. Taiho Pharmaceuticals Co., Ltd. Zymeworks |
Abbott Laboratories Amgen Inc. Astellas Pharma US, Inc. AstraZeneca Pharmaceuticals LP BeiGene Bristol Myers Squibb Daiichi- Sankyo Co. Gilead Sciences, Inc. Jazz Pharmaceuticals Inc. Kyowa Hakko Kirin Co., Ltd. Merck & Co., Inc. Novartis Pharmaceuticals Corporation Servier zymeworks |
None | None | 04/19/2024 |
| Afsaneh Barzi PhD,MD | Bayer HealthCare | None | None | None | 01/10/2024 |
| David Bentrem MD,MS | None | None | None | None | 03/30/2024 |
| Marian Birkeland PhD | None | None | None | None | 04/02/2024 |
| Nicole Blankenhorn | None | None | None | None | 03/04/2024 |
| David Cooke MD,FACS | None | None | Bristol Myers Squibb | None | 02/14/2024 |
| Carlos Corvera MD,FACS | None | None | None | None | 04/13/2024 |
| Thomas D'Amico MD | None | None | None | None | 04/02/2024 |
| Prajnan Das MD,MPH,MS | None | None | None | None | 04/10/2024 |
| Peter Enzinger MD | None | ALX Oncology Amgen Inc. Arcus Bioscience Astellas Pharma US, Inc. AstraZeneca Pharmaceuticals LP Bayer HealthCare BeiGene Chimeric Therapeutics Coherus Daiichi- Sankyo Co. Eisai Inc. Ideaya Legend Loxo Merck & Co., Inc. Novartis Pharmaceuticals Corporation Ono Regeneron Pharmaceuticals, Inc. sanofi-aventis U.S. Servier Taiho Pharmaceuticals Co., Ltd. Takeda Pharmaceuticals North America, Inc. Turning Point Therapeutics Xencor Zymeworks |
None | None | 04/19/2024 |
| Thomas Enzler PhD,MD | None | None | None | None | 04/20/2024 |
| Tanya Fischer MLIS,MEd | None | None | None | None | 04/22/2024 |
| Hans Gerdes MD | None | None | None | None | 01/07/2024 |
| Michael Gibson MD,PhD,FACP | AbbVie, Inc. Papivax |
Astellas Pharma US, Inc. Coheres Daiichi- Sankyo Co. UpToDate |
None | None | 03/27/2024 |
| Kristina Gregory MSN,RN | None | None | None | None | 01/10/2024 |
| Patrick Grierson MD,PhD | Aclaris Therapeutics | None | None | None | 11/16/2023 |
| Evelyn Handel PharmD,BCPS,BCOP | None | None | None | None | 02/02/2024 |
| Lisa Hang PhD | None | None | None | Abbott Laboratories (spouse)|Abbvie (spouse)|BD (spouse) | 02/20/2024 |
| Erin Hesler | None | None | None | None | 12/22/2023 |
| Wayne Hofstetter MD | AstraZeneca Pharmaceuticals LP | None | None | None | 04/08/2024 |
| David Ilson MD,PhD | None | Amgen Inc. Astellas Pharma US, Inc. AstraZeneca Pharmaceuticals LP Bayer HealthCare Bristol Myers Squibb Daiichi- Sankyo Co. Eli Lilly and Company Merck & Co., Inc. Roche Laboratories, Inc. Taiho Pharmaceuticals Co., Ltd. |
None | Amgen Inc. |Astellas Pharma US, Inc.|AstraZeneca Pharmaceuticals LP |Bayer HealthCare |Bristol Myers Squibb|Daiichi- Sankyo Co.|MacroGenics|Merck & Co., Inc.|Roche Laboratories, Inc.|Taiho Pharmaceuticals Co., Ltd. | 03/05/2024 |
| Shadia Jalal MD | TESARO, Inc. | None | None | None | 03/03/2024 |
| Rajesh Keswani MD | None | Boston Scientific Corporation Medtronic, Inc. |
None | None | 04/08/2024 |
| Sunnie Kim MD | None | Astellas Pharma US, Inc. Bristol Myers Squibb Eisai Inc. IMAB Merck & Co., Inc. |
None | None | 02/13/2024 |
| Lawrence Kleinberg MD | Bristol Myers Squibb Incyte Corporation Novartis Pharmaceuticals Corporation Novocure |
Servier | None | None | 04/13/2024 |
| Samuel Klempner MD | Arcus Astellas Pharma US, Inc. I-Mab Leap Therapeutics Mersana Profound |
Amgen Inc. Astellas Pharma US, Inc. AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Daiichi- Sankyo Co. Merck & Co., Inc. Novartis Pharmaceuticals Corporation sanofi-aventis U.S. Taiho Pharmaceuticals Co., Ltd. |
Research to Practice -- CME | None | 04/09/2024 |
| Jill Lacy MD | None | ASCO Bristol Myers Squibb FirstWorld Genentech, Inc. Guidepoint Ipsen MarketPlus Medical Mutual Insurance Co Techspert |
None | None | 02/11/2024 |
| Byrne Lee MD,FACS | None | None | None | None | 04/09/2024 |
| Frank Licciardi | None | None | None | None | 12/12/2023 |
| Shane Lloyd MD | None | Cancer Study Group Expert Witness Naveris |
None | None | 04/10/2024 |
| Quan Ly MD | None | None | None | Amgen Inc. |Bayer HealthCare |Biogen Idec|Bristol Myers Squibb|Intuitive Surgical, Inc.|Merck & Co., Inc.|Novartis Pharmaceuticals Corporation |Pfizer Inc. | 04/05/2024 |
| Christine McLaughlin | None | None | None | None | 03/28/2024 |
| Nicole McMillian MS | None | None | None | None | 04/22/2024 |
| Michael McNamara MD | None | None | None | None | 04/03/2024 |
| Ryan Merkow MD,MS | None | None | Intera Oncology | None | 04/15/2024 |
| Aaron Miller PhD,MD | None | None | None | None | 04/13/2024 |
| Sarbajit Mukherjee MD,MS | Ipsen | None | None | Esophageal Cancer Action Network | 04/08/2024 |
| Mary Mulcahy MD | None | None | None | None | 03/03/2024 |
| Darryl Outlaw MD | None | None | None | None | 04/09/2024 |
| Sharon Park PharmD,BCOP | None | None | None | None | 02/09/2024 |
| Kyle Perry MD | None | None | None | None | 04/01/2024 |
| Jose Pimiento MD | None | ADVOCARE, wellness company Astellas Pharma US, Inc. |
None | None | 04/10/2024 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 03/13/2024 |
| Deepti Reddi MD | None | None | None | None | 01/10/2024 |
| Scott Reznik MD | None | None | None | Onconano | 04/08/2024 |
| Robert Roses MD | None | None | None | None | 01/22/2024 |
| MaryElizabeth Stein PhD | None | None | None | None | 04/17/2024 |
| Vivian Strong MD | None | None | Merck & Co., Inc. | None | 02/14/2024 |
| Stacey Su MD | None | None | None | None | 06/02/2023 |
| Samantha Tamburro OCN,RN,BSN | None | None | None | None | 04/24/2024 |
| Nataliya Uboha MD,PhD | Arcus Ipsen |
Astellas Pharma US, Inc. AstraZeneca Pharmaceuticals LP Elevation Oncology Eli Lilly and Company Ipsen |
None | Natera | 03/18/2024 |
| Zev Wainberg MD | Amgen Inc. Arcus AstraZeneca Pharmaceuticals LP Daiichi- Sankyo Co. Genentech, Inc. Ipsen Merck & Co., Inc. Novartis Pharmaceuticals Corporation Pfizer Inc. SeaGen |
Amgen Inc. Arcus Astellas Pharma US, Inc. Boehringer Ingelheim GmbH Daiichi- Sankyo Co. Eisai Inc. Genentech, Inc. Ipsen Merck & Co., Inc. Novartis Pharmaceuticals Corporation Regeneron Pharmactcls Revolution Medicine |
None | None | 04/10/2024 |
| Georgia Wiesner MD | None | None | None | None | 01/15/2024 |
| Christopher Willett MD | None | None | None | None | 06/29/2023 |
| Harry Yoon MD | Amgen Inc. BeiGene Bristol Myers Squibb CARsgen Elevar Merck & Co., Inc. |
Amgen Inc. Astellas Pharma US, Inc. AstraZeneca Pharmaceuticals LP AstraZeneca/Daiichi Sankyo BeiGene Bristol Myers Squibb Elevation Oncology Merck & Co., Inc. Novartis-Tisle |
None | None | 04/03/2024 |